List your tool

Head to head · 2026

Paige vs Proscia

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Paige

Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025

4.1Not listed

Visit Paige (opens Paige in a new tab)

Proscia

FDA-cleared digital pathology platform for primary diagnosis and biomarker research

4.3Not listed

Visit Proscia (opens Proscia in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Paige does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Proscia

    4.1 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onPaigeProscia
Our rating4.14.3Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Paige Alba AI co-pilot for digital pathology tissue-slide analysis
  • Cancer diagnosis, tissue subtyping, and molecular biomarker discovery support
  • Founded in 2017 by researchers from Memorial Sloan Kettering Cancer Center
  • Acquired by Tempus in August 2025, continuing under its own brand
  • Enterprise deployment with dedicated support for hospital and lab pathology teams
  • FDA-cleared for primary clinical diagnosis in AP-Dx
  • Concentriq AP, AP-Dx and LS configurations
  • Biomarker research and clinical trial workflows
  • Cloud deployment
  • Predetermined Change Control Plan for regulatory compliance
Pros
  • Research pedigree from Memorial Sloan Kettering lends real clinical credibility
  • Tempus backing adds financial resources and precision-medicine data integration
  • Deep oncology pathology specialization outperforms general-purpose medical imaging AI
  • FDA clearance for primary diagnosis, not just research viewing
  • Deployed across 4,000 hospitals and 16 of the top 20 pharma companies
  • Rated highest in KLAS 2026 in both the US and Europe
Cons
  • Enterprise-only pricing requires a sales conversation before evaluation
  • Now part of a larger company, a real change from its independent-startup years
  • Narrow pathology focus means it's not a fit for non-oncology diagnostic workflows
  • No published pricing
  • Requires compatible scanning hardware
  • Adoption is a laboratory-wide programme, not a purchase
CompanyPaige, founded 2017Proscia Inc.

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is Paige better than Proscia?

In our reviews Paige scores 4.1 and Proscia scores 4.3. The better pick depends on the job. Paige: Digital pathology AI co-pilot from Memorial Sloan Kettering researchers, acquired by Tempus in 2025. Proscia: FDA-cleared digital pathology platform for primary diagnosis and biomarker research.

Which is cheaper, Paige or Proscia?

Paige: see pricing. Proscia: see pricing.

Do Paige and Proscia have free plans?

Neither lists a free plan.

More comparisons